Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.

[1]  A. Messadi,et al.  Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004. , 2008, Burns : journal of the International Society for Burn Injuries.

[2]  G. Bloemsma,et al.  Mortality and causes of death in a burn centre. , 2008, Burns : journal of the International Society for Burn Injuries.

[3]  E. Salehifar,et al.  Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism. , 2008, Burns : journal of the International Society for Burn Injuries.

[4]  H. Ashour,et al.  Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt. , 2008, The Journal of urology.

[5]  Z. Iqbal,et al.  Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. , 2008, Pakistan journal of pharmaceutical sciences.

[6]  M. Mulvey,et al.  Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study. , 2008, Diagnostic microbiology and infectious disease.

[7]  D. Nicolau.  Carbapenems: a potent class of antibiotics , 2008, Expert opinion on pharmacotherapy.

[8]  B. Markova,et al.  Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. , 2007, Journal of medical microbiology.

[9]  E. Tredget,et al.  The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. , 2007, The Journal of trauma.

[10]  P. Lebecque,et al.  Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  D. Hocquet,et al.  Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study. , 2007, The Journal of antimicrobial chemotherapy.

[12]  F. Ikeda,et al.  In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa , 2006, Antimicrobial Agents and Chemotherapy.

[13]  Ronald N. Jones,et al.  Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. , 2006, Diagnostic microbiology and infectious disease.

[14]  J. Sankar,et al.  Infections in burn patients--experience in a tertiary care hospital. , 2006, Burns : journal of the International Society for Burn Injuries.

[15]  M. Kalani,et al.  Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran. , 2006, Burns : journal of the International Society for Burn Injuries.

[16]  Yehuda Carmeli,et al.  Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact , 2006, Antimicrobial Agents and Chemotherapy.

[17]  A. Malik,et al.  Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients. , 2005, The Indian journal of medical research.

[18]  A. Evangelista,et al.  Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  K. Poole.  Aminoglycoside Resistance in Pseudomonas aeruginosa , 2005, Antimicrobial Agents and Chemotherapy.

[20]  M. Akçay,et al.  The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. , 2004, Burns : journal of the International Society for Burn Injuries.

[21]  R. MacLaren,et al.  Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. , 2004, The Journal of hospital infection.

[22]  Z. Astal.  Susceptibility Patterns in Pseudomonas aeruginosa Causing Nosocomial Infections , 2004, Journal of chemotherapy.

[23]  N. Elkhizzi,et al.  Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa. , 2004, Saudi medical journal.

[24]  V. Gupta,et al.  Aerobic bacterial isolates from burn wound infections and their antibiograms--a five-year study. , 2004, Burns : journal of the International Society for Burn Injuries.

[25]  S. Logsetty,et al.  Pseudomonas infections in the thermally injured patient. , 2004, Burns : journal of the International Society for Burn Injuries.

[26]  J. Shimada,et al.  In Vivo Antibacterial Activity of S-3578, a New Broad-Spectrum Cephalosporin: Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Experimental Infection Models , 2003, Antimicrobial Agents and Chemotherapy.

[27]  M. Makoka,et al.  Bacteriology of burns at the Queen Elizabeth Central Hospital, Blantyre, Malawi. , 2003, Burns : journal of the International Society for Burn Injuries.

[28]  J. Karlowsky,et al.  Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001 , 2003, Antimicrobial Agents and Chemotherapy.

[29]  I. Kaur,et al.  Changing trends in bacteriology of burns in the burns unit, Delhi, India. , 2003, Burns : journal of the International Society for Burn Injuries.

[30]  J. Eldere.  Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections , 2003 .

[31]  P. Bradford,et al.  Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  P. Mathur,et al.  Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. , 2002, The Indian journal of medical research.

[33]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  R. Sharma,et al.  Bacteriology of burn wounds--the first three years in a new burn unit at the Medical College Chandigarh. , 2001, Burns : journal of the International Society for Burn Injuries.

[35]  Ronald N. Jones,et al.  Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  M. Nicolas-Chanoine,et al.  Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996). , 2000, The Journal of antimicrobial chemotherapy.

[37]  D. Livermore,et al.  Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. , 2000, The Journal of antimicrobial chemotherapy.

[38]  J. Lucet,et al.  Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  S. Oie,et al.  In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa. , 1999, The Journal of antimicrobial chemotherapy.

[40]  L S Gonzalez,et al.  Aminoglycosides: a practical review. , 1998, American family physician.

[41]  R. Alaghehbandan,et al.  Pseudomonas infections in Tohid Burn Center, Iran. , 1998, Burns : journal of the International Society for Burn Injuries.

[42]  R. Hancock.  Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  B. K. Jain,et al.  Bacteriology of burns. , 1998, Burns : journal of the International Society for Burn Injuries.

[44]  J. Ariza,et al.  Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases , 1998, Antimicrobial Agents and Chemotherapy.

[45]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[46]  B. Katzung,et al.  Pharmacology: Examination & Board Review , 1996 .

[47]  K S Meyer,et al.  Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins , 1993, Annals of Internal Medicine.

[48]  G. Jacoby,et al.  Extended-spectrum beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.

[49]  V. Yu,et al.  Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new. , 1987, Diagnostic microbiology and infectious disease.

[50]  H. Suginaka,et al.  Penicillin-Resistant Mechanisms in Pseudomonas aeruginosa: Binding of Penicillin to Pseudomonas aeruginosa KM 338 , 1975, Antimicrobial Agents and Chemotherapy.

[51]  H. Stone.  Review of Pseudomonas Sepsis in Thermal Burns: Verdoglobin Determination and Gentamicin Therapy , 1966, Annals of surgery.

[52]  A. Chaudhury.  In vitro activity of cefpirome: a new fourth generation cephalosporin. , 2003, Indian journal of medical microbiology.

[53]  D. Shlaes,et al.  The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  F. Goldstein,et al.  Trends in bacterial resistance to fluoroquinolones. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  R. Atlas.  Microbiology: Fundamentals and applications , 1984 .

[56]  N. Westerdaal,et al.  In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin. , 1979, Chemotherapy.

[57]  Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2022 .